因美纳将收购数据驱动蛋白质组学技术领域领先企业SomaLogic

美通社头条
25 Jun

、美通社消息:6月23日,因美纳公司宣布,已与Standard BioTools达成最终协议。根据该协议,因美纳将以3.5亿美元现金收购数据驱动蛋白质组学技术领域的领先企业SomaLogic及其他指定资产,该现金款项将在交易完成时支付,并根据惯例进行调整,外加高达7,500万美元的近期绩效里程碑款项及业绩相关版税。SomaLogic在全球拥有约250名员工,涵盖商业、研发、实验室运营、制造及其他...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10